Bradykinin receptor antagonists have therapeutic potential in conditions such as hereditary angioedema, chronic pain, and inflammatory diseases. By blocking the bradykinin receptors, these antagonists can reduce excessive inflammation and pain, providing relief in various clinical scenarios. For instance, icatibant, a B2 receptor antagonist, is specifically used to treat acute attacks of hereditary angioedema.
